Modular Medical (MODD) Competitors $2.20 +0.03 (+1.38%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MODD vs. ZYXI, RCEL, SGHT, LUNG, SMLR, NVRO, SKIN, ELMD, NPCE, and PROFShould you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include Zynex (ZYXI), AVITA Medical (RCEL), Sight Sciences (SGHT), Pulmonx (LUNG), Semler Scientific (SMLR), Nevro (NVRO), Beauty Health (SKIN), Electromed (ELMD), NeuroPace (NPCE), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry. Modular Medical vs. Zynex AVITA Medical Sight Sciences Pulmonx Semler Scientific Nevro Beauty Health Electromed NeuroPace Profound Medical Zynex (NASDAQ:ZYXI) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Does the MarketBeat Community prefer ZYXI or MODD? Zynex received 26 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 57.14% of users gave Zynex an outperform vote. CompanyUnderperformOutperformZynexOutperform Votes2857.14% Underperform Votes2142.86% Modular MedicalOutperform Votes2100.00% Underperform VotesNo Votes Do insiders & institutionals believe in ZYXI or MODD? 29.7% of Zynex shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 52.1% of Zynex shares are held by company insiders. Comparatively, 32.3% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is ZYXI or MODD more profitable? Zynex has a net margin of 2.49% compared to Modular Medical's net margin of 0.00%. Zynex's return on equity of 13.05% beat Modular Medical's return on equity.Company Net Margins Return on Equity Return on Assets Zynex2.49% 13.05% 3.78% Modular Medical N/A -228.12%-178.09% Do analysts prefer ZYXI or MODD? Zynex presently has a consensus target price of $14.00, indicating a potential upside of 59.82%. Modular Medical has a consensus target price of $5.00, indicating a potential upside of 127.27%. Given Modular Medical's higher possible upside, analysts plainly believe Modular Medical is more favorable than Zynex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Modular Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to ZYXI or MODD? In the previous week, Zynex had 7 more articles in the media than Modular Medical. MarketBeat recorded 8 mentions for Zynex and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.45 beat Zynex's score of 0.10 indicating that Modular Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zynex 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Modular Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, ZYXI or MODD? Zynex has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Which has better earnings and valuation, ZYXI or MODD? Zynex has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZynex$184.32M1.51$9.73M$0.1558.40Modular MedicalN/AN/A-$17.47M-$0.68-3.24 SummaryZynex beats Modular Medical on 12 of the 16 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get Modular Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MODD vs. The Competition Export to ExcelMetricModular MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.63M$4.45B$5.40B$8.53BDividend YieldN/A42.37%5.15%4.14%P/E Ratio-3.2437.84113.7615.14Price / SalesN/A64.751,483.0493.53Price / CashN/A49.2739.7134.04Price / Book6.114.214.665.01Net Income-$17.47M$11.52M$119.06M$225.46M7 Day Performance-0.90%1.05%0.79%0.37%1 Month Performance-3.08%0.94%5.65%3.57%1 Year Performance83.33%39.40%36.80%29.42% Modular Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MODDModular Medical3.6131 of 5 stars$2.20+1.4%$5.00+127.3%+81.8%$71.63MN/A-3.2439Positive NewsZYXIZynex3.7459 of 5 stars$8.76+1.5%$14.00+59.8%-1.5%$279.01M$184.32M58.401,100Gap DownRCELAVITA Medical1.1374 of 5 stars$10.30+2.0%$15.00+45.6%+5.6%$267.70M$54.14M-5.28130Upcoming EarningsNews CoverageSGHTSight Sciences2.5214 of 5 stars$5.21+4.2%$7.25+39.2%+229.7%$262.12M$81.06M-4.87210Upcoming EarningsLUNGPulmonx2.6535 of 5 stars$6.27+0.3%$14.67+133.9%-30.9%$245.47M$68.68M-4.27250Analyst ForecastNews CoverageSMLRSemler Scientific1.463 of 5 stars$30.68+4.4%N/A+7.2%$214.52M$61.74M15.0492Upcoming EarningsNVRONevro2.5874 of 5 stars$5.53+0.4%$9.80+77.2%-62.0%$206.18M$426.10M-2.601,215Analyst UpgradeSKINBeauty Health2.9254 of 5 stars$1.66+2.5%$2.46+48.1%-58.1%$205.87M$398M-2.001,030ELMDElectromedN/A$22.90-1.5%N/A+118.9%$192.36M$54.72M39.48174NPCENeuroPace3.3071 of 5 stars$6.29-2.5%$14.00+122.6%-8.8%$183.67M$65.42M-5.77170PROFProfound Medical2.172 of 5 stars$7.35+1.1%$13.75+87.1%-13.3%$179.29M$7.20M-6.02150Upcoming EarningsNews Coverage Related Companies and Tools Related Companies ZYXI Alternatives RCEL Alternatives SGHT Alternatives LUNG Alternatives SMLR Alternatives NVRO Alternatives SKIN Alternatives ELMD Alternatives NPCE Alternatives PROF Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MODD) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Modular Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Modular Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
